DarioHealth Corp.
DRIO
$8.00
$0.506.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.23M | 5.01M | 5.37M | 6.75M | 7.60M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.23M | 5.01M | 5.37M | 6.75M | 7.60M |
| Cost of Revenue | 2.25M | 1.81M | 1.97M | 2.00M | 2.11M |
| Gross Profit | 2.99M | 3.20M | 3.40M | 4.76M | 5.49M |
| SG&A Expenses | 8.73M | 9.17M | 8.44M | 9.18M | 9.86M |
| Depreciation & Amortization | 181.00K | 181.00K | 433.00K | 875.00K | 1.29M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.79M | 14.49M | 14.57M | 16.16M | 18.54M |
| Operating Income | -8.56M | -9.48M | -9.20M | -9.41M | -10.94M |
| Income Before Tax | -8.95M | -10.47M | -12.99M | -9.21M | -9.48M |
| Income Tax Expenses | 83.00K | -- | -- | 22.00K | 155.00K |
| Earnings from Continuing Operations | -9.03M | -10.47M | -12.99M | -9.23M | -9.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.03M | -10.47M | -12.99M | -9.23M | -9.63M |
| EBIT | -8.56M | -9.48M | -9.20M | -9.41M | -10.94M |
| EBITDA | -8.03M | -8.94M | -8.40M | -8.15M | -8.80M |
| EPS Basic | -2.04 | -2.96 | -3.54 | -2.87 | -2.48 |
| Normalized Basic EPS | -0.71 | -2.08 | -3.27 | -2.43 | -1.39 |
| EPS Diluted | -2.04 | -2.96 | -3.54 | -2.87 | -2.48 |
| Normalized Diluted EPS | -0.71 | -2.08 | -3.27 | -2.43 | -1.39 |
| Average Basic Shares Outstanding | 7.91M | 3.14M | 2.48M | 2.37M | 3.94M |
| Average Diluted Shares Outstanding | 7.91M | 3.14M | 2.48M | 2.37M | 3.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |